首页
探索
nav.journalClub
趋势
更多
Synapse
⌘+K
Synapse
语言
简体中文
简体中文
Biopsy RNA-seq captures TROP-2–linked migration and clonal resistance to forecast aggressiveness in metastatic melanoma | Synapse
March 3, 2026
Open Access
Biopsy RNA-seq captures TROP-2–linked migration and clonal resistance to forecast aggressiveness in metastatic melanoma
MB
M. Betti
National Cancer Institute
CA
Celeste Accetta
National Cancer Institute
BA
Brindusa Ana Maria Arteni
National Cancer Institute
See all
Key Points
Capturing TROP-2 linked migration and clonal resistance forecasts melanoma aggressiveness.
The study highlights how RNA-seq can reveal critical tumor dynamics and treatment implications.
Analysis through biopsy RNA-seq characterizes tumor behavior and potential resistance mechanisms.
This finding may enable personalized treatment strategies in clinical settings; further studies needed.
Read Full Paper
externally
问 AI
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
问 AI
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
Betti et al. (Wed,) studied this question.
synapsesocial.com/papers/69a75be4c6e9836116a240b9
https://doi.org/https://doi.org/10.1186/s13046-026-03646-1